3-nitrobenzothiazolo(3,2-a)quinolinium has been researched along with bicuculline in 1 studies
Studies (3-nitrobenzothiazolo(3,2-a)quinolinium) | Trials (3-nitrobenzothiazolo(3,2-a)quinolinium) | Recent Studies (post-2010) (3-nitrobenzothiazolo(3,2-a)quinolinium) | Studies (bicuculline) | Trials (bicuculline) | Recent Studies (post-2010) (bicuculline) |
---|---|---|---|---|---|
14 | 0 | 0 | 6,253 | 3 | 759 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JT; Calver, AR; Collingridge, GL; Davies, CH; Randall, A; Thuault, SJ | 1 |
1 other study(ies) available for 3-nitrobenzothiazolo(3,2-a)quinolinium and bicuculline
Article | Year |
---|---|
Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit.
Topics: 4-Aminopyridine; Animals; Bicuculline; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Epilepsy; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Gene Deletion; Hippocampus; In Vitro Techniques; Magnesium; Membrane Potentials; Mice; Mice, Knockout; Phosphinic Acids; Potassium Channel Blockers; Propanolamines; Pyramidal Cells; Quinolinium Compounds; Receptors, GABA-B; Time Factors; Valine | 2005 |